Three Times Weekly Symptom Screening for Children With Cancer
Launched by THE HOSPITAL FOR SICK CHILDREN · Feb 14, 2020
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well children with cancer can report their symptoms using a web-based tool called SPARK. The goal is to see if children can easily share their symptoms three times a week for eight weeks. SPARK helps children and their families understand how to manage symptoms they might experience during treatment, like side effects from chemotherapy or surgery, and sends updates to their healthcare providers to keep everyone informed.
To join the study, children must be between the ages of 2 and 18 and have a cancer diagnosis. They should be currently receiving or scheduled to receive treatments like chemotherapy, radiation, or surgery. Participants will fill out symptom reports three times a week, and the study will provide helpful feedback based on their answers. It's important to know that children with certain disabilities that affect their ability to see or understand the tool won't be eligible for this trial. This study is not yet recruiting participants, but it aims to make symptom reporting easier and more effective for young cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • cancer diagnosis
- • 2-18 years of age at enrollment
- • Child has received or a plan for any chemotherapy, radiotherapy or surgery
- • Understands English, French or Spanish
- Exclusion Criteria:
- • Cognitive disability
- • Visual impairment (cannot see SPARK even with corrective lens)
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Lillian Sung, MD, PhD
Principal Investigator
The Hospital for Sick Children
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials